Continuing a string of acquisitions and openings in Arizona, Curaleaf Holdings, Inc. (CSE: CURA; OTCQX: CURLF) just bumped its state dispensary count up to seven with the Curaleaf Pavilions site.
That storefront is now open for business and is named for its proximity to the Ak-Chin Pavilion Ampitheater in the Phoenix metro area.
The license for the Curaleaf Pavilions site was picked up via the acquisition of Phytotherapeutics Management Services, LLC earlier this year. Including the recent buyout of Glendale Greenhouse, this latest move marks the third acquisition Curaleaf has completed in the state, significantly increasing the company’s overall footprint in Arizona.
Remarking on the company’s recent statewide expansion efforts and the new dispensary opening this morning, CEO Joe Lusardi commented:
The new storefront’s grand opening celebration will be held on Friday, Oct. 4 to introduce the dispensary team to the local community and to offer a variety of discounts and prizes. Aside from that grand opening, the store will offer three new patient deals to bring in additional clients.
Specifically, a Buy One Get One deal is available for all first-time patients — a deal that can be doubled by visiting the existing Glendale or Gilbert locations — while a free pre-rolled product is provided on the patient’s second visit, followed by a free gram on the third visit.
Aside from Arizona operations, Curaleaf has expanded in Florida over the last month by releasing new cannabis tablets to the state’s medical market, as well as opening a new dispensary in the Port Charlotte area.
The multi-state operator’s stock is finally back on an upward trajectory after the sudden spring drop off that saw nearly every company in the industry take a major hit on its stock price. Curaleaf crossed the eight dollar threshold and is now trading at $8.05 this morning, up from the $6.63 a share asking price from this same time last month.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.